{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-242001","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2022-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.314017+00:00","generated_at":"2026-06-23T11:58:03.716187+00:00","sec_items":["3.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Minerva Neurosciences transfers stock listing to Nasdaq Capital Market to avoid delisting","bullets":["Transfer from Nasdaq Global Market to Nasdaq Capital Market effective Sept 12, 2022; ticker NERV unchanged.","Company was not in compliance with minimum $10M net equity requirement previously disclosed on March 8, 2022.","Nasdaq approved transfer under Listing Rule 5810(c)(3)(A); company meets all Capital Market continued listing criteria.","No impact on trading; press release issued Sept 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-242001","json":"https://secwatch.observer/filing/0001193125-22-242001.json","markdown":"https://secwatch.observer/filing/0001193125-22-242001.md","text":"https://secwatch.observer/filing/0001193125-22-242001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522242001/0001193125-22-242001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522242001/d382794d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:58:03.716187+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}